Neurocrine Biosciences Is A Biopharmaceutical Company Based In San Diegocaliforniafounded In 1992With Over 1 700 Employeesthe Company Focuses On Developing Treatments For Neurological And Endocrine Related Disordersneurocrine Conducts Extensive Clinical Trials And Research In Areas Such As Movement Disordersepilepsyand Congenital Adrenal Hyperplasiaoften Collaborating With Other Pharmaceutical Companies To Enhance Its Product Development And Distribution The Company Offers Several Fda Approved Treatmentsincluding Ingrezzaa Medication For Tardive Dyskinesia And Chorea Associated With Huntingtonae S Diseaseand Orilissawhich Is Used To Treat Endometriosis Associated Painneurocrine Also Provides Treatments For Classic Congenital Adrenal Hyperplasiaaddressing The Needs Of Patients With Rare And Under Addressed Diseasestheir Mission Emphasizes A Commitment To Scientific Excellence And Patient Centricityaiming To Improve Access To Innovative Therapies For Underserved Populations
